HeraMED (ASX:HMD) FCF Margin % : -1,157.38% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is HeraMED FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. HeraMED's Free Cash Flow for the six months ended in Dec. 2024 was A$-2.12 Mil. HeraMED's Revenue for the six months ended in Dec. 2024 was A$0.18 Mil. Therefore, HeraMED's FCF Margin % for the quarter that ended in Dec. 2024 was -1,157.38%.

As of today, HeraMED's current FCF Yield % is -37.10%.

The historical rank and industry rank for HeraMED's FCF Margin % or its related term are showing as below:

ASX:HMD' s FCF Margin % Range Over the Past 10 Years
Min: -7258.82 Med: -2014.9 Max: -943.15
Current: -1338.74

During the past 7 years, the highest FCF Margin % of HeraMED was -943.15%. The lowest was -7258.82%. And the median was -2014.90%.

ASX:HMD's FCF Margin % is ranked worse than
94.51% of 819 companies
in the Medical Devices & Instruments industry
Industry Median: -3.57 vs ASX:HMD: -1338.74

HeraMED FCF Margin % Historical Data

The historical data trend for HeraMED's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeraMED FCF Margin % Chart

HeraMED Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-7,258.82

-3,813.33

-1,484.16

-943.15

-1,322.53

HeraMED Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial								-1,371.19	-850.00	-1,042.16	-1,522.10	-1,157.38

Competitive Comparison of HeraMED's FCF Margin %

For the Medical Devices subindustry, HeraMED's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeraMED's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeraMED's FCF Margin % distribution charts can be found below:

* The bar in red indicates where HeraMED's FCF Margin % falls into.

Save Embed

;

Save Embed

;

HeraMED FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

HeraMED's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-4.814	/	0.364
	=	-1,322.53 %

HeraMED's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-2.118	/	0.183
	=	-1,157.38 %

HeraMED FCF Margin % Related Terms

Thank you for viewing the detailed overview of HeraMED's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

HeraMED Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeraMED Ltd (ASX:HMD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

201, 697 Burke Road, Suite 4, Camberwell, VIC, AUS, 3124

Website

https://www.hera-med.com

HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel.

HeraMED Headlines

No Headlines